Specialty Retail
Compare Stocks
4 / 10Stock Comparison
EYE vs AMSF vs NVST vs KNTK
Revenue, margins, valuation, and 5-year total return — side by side.
Insurance - Specialty
Medical - Equipment & Services
Oil & Gas Midstream
EYE vs AMSF vs NVST vs KNTK — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||||
|---|---|---|---|---|
| Industry | Specialty Retail | Insurance - Specialty | Medical - Equipment & Services | Oil & Gas Midstream |
| Market Cap | $1.81B | $569M | $4.04B | $3.33B |
| Revenue (TTM) | $1.99B | $325M | $2.81B | $1.73B |
| Net Income (TTM) | $30M | $46M | $68M | $228M |
| Gross Margin | 56.5% | 47.6% | 55.1% | 24.8% |
| Operating Margin | 3.0% | 17.8% | 9.0% | 8.2% |
| Forward P/E | 32.6x | 14.4x | 17.2x | 42.4x |
| Total Debt | $695M | $491K | $1.71B | $3.87B |
| Cash & Equiv. | $39M | $62M | $1.21B | $4M |
EYE vs AMSF vs NVST vs KNTK — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| National Vision Hol… (EYE) | 100 | 85.3 | -14.7% |
| AMERISAFE, Inc. (AMSF) | 100 | 49.4 | -50.6% |
| Envista Holdings Co… (NVST) | 100 | 114.9 | +14.9% |
| Kinetik Holdings In… (KNTK) | 100 | 702.3 | +602.3% |
Price return only. Dividends and distributions are not included.
Quick Verdict: EYE vs AMSF vs NVST vs KNTK
Each card shows where this stock fits in a portfolio — not just who wins on paper.
EYE is the clearest fit if your priority is momentum.
- +46.3% vs AMSF's -29.2%
AMSF carries the broadest edge in this set and is the clearest fit for long-term compounding and sleep-well-at-night.
- 31.8% 10Y total return vs NVST's -13.1%
- Lower volatility, beta 0.23, Low D/E 0.2%, current ratio 0.32x
- Lower P/E (14.4x vs 42.4x)
- 14.3% margin vs EYE's 1.5%
NVST lags the leaders in this set but could rank higher in a more targeted comparison.
KNTK is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 3 yrs, beta 0.60, yield 16.5%
- Rev growth 19.0%, EPS growth 157.8%, 3Y rev CAGR 13.3%
- Beta 0.60, yield 16.5%, current ratio 0.69x
- 19.0% revenue growth vs AMSF's 2.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 19.0% revenue growth vs AMSF's 2.6% | |
| Value | Lower P/E (14.4x vs 42.4x) | |
| Quality / Margins | 14.3% margin vs EYE's 1.5% | |
| Stability / Safety | Beta 0.23 vs NVST's 1.65, lower leverage | |
| Dividends | 16.5% yield, 3-year raise streak, vs AMSF's 8.4%, (2 stocks pay no dividend) | |
| Momentum (1Y) | +46.3% vs AMSF's -29.2% | |
| Efficiency (ROA) | 5.6% ROA vs NVST's 1.2%, ROIC 21.9% vs 4.8% |
EYE vs AMSF vs NVST vs KNTK — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
EYE vs AMSF vs NVST vs KNTK — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
AMSF leads in 2 of 6 categories
KNTK leads 2 • EYE leads 0 • NVST leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — EYE and AMSF each lead in 2 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
NVST is the larger business by revenue, generating $2.8B annually — 8.6x AMSF's $325M. AMSF is the more profitable business, keeping 14.3% of every revenue dollar as net income compared to EYE's 1.5%. On growth, EYE holds the edge at +15.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||||
|---|---|---|---|---|
| RevenueTrailing 12 months | $2.0B | $325M | $2.8B | $1.7B |
| EBITDAEarnings before interest/tax | $153M | $58M | $342M | $534M |
| Net IncomeAfter-tax profit | $30M | $46M | $68M | $228M |
| Free Cash FlowCash after capex | $73M | $8M | $220M | $441M |
| Gross MarginGross profit ÷ Revenue | +56.5% | +47.6% | +55.1% | +24.8% |
| Operating MarginEBIT ÷ Revenue | +3.0% | +17.8% | +9.0% | +8.2% |
| Net MarginNet income ÷ Revenue | +1.5% | +14.3% | +2.4% | +13.2% |
| FCF MarginFCF ÷ Revenue | +3.7% | +2.5% | +7.8% | +25.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +15.1% | +10.3% | +14.4% | -7.5% |
| EPS Growth (YoY)Latest quarter vs prior year | +111.3% | -8.5% | +130.0% | -2.4% |
Valuation Metrics
AMSF leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 12.3x trailing earnings, AMSF trades at a 86% valuation discount to NVST's 86.7x P/E. On an enterprise value basis, AMSF's 8.5x EV/EBITDA is more attractive than EYE's 16.2x.
| Metric | ||||
|---|---|---|---|---|
| Market CapShares × price | $1.8B | $569M | $4.0B | $3.3B |
| Enterprise ValueMkt cap + debt − cash | $2.5B | $508M | $4.5B | $7.2B |
| Trailing P/EPrice ÷ TTM EPS | 61.70x | 12.27x | 86.73x | 18.43x |
| Forward P/EPrice ÷ next-FY EPS est. | 32.60x | 14.42x | 17.21x | 42.44x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 58.08x | — |
| EV / EBITDAEnterprise value multiple | 16.20x | 8.53x | 13.28x | 13.14x |
| Price / SalesMarket cap ÷ Revenue | 0.91x | 1.80x | 1.49x | 1.89x |
| Price / BookPrice ÷ Book value/share | 2.12x | 2.30x | 1.32x | 1.04x |
| Price / FCFMarket cap ÷ FCF | 24.68x | 63.83x | 17.54x | 44.78x |
Profitability & Efficiency
AMSF leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
KNTK delivers a 21.1% return on equity — every $100 of shareholder capital generates $21 in annual profit, vs $2 for NVST. AMSF carries lower financial leverage with a 0.00x debt-to-equity ratio, signaling a more conservative balance sheet compared to KNTK's 1.32x. On the Piotroski fundamental quality scale (0–9), EYE scores 7/9 vs KNTK's 4/9, reflecting strong financial health.
| Metric | ||||
|---|---|---|---|---|
| ROE (TTM)Return on equity | +3.5% | +9.7% | +2.2% | +21.1% |
| ROA (TTM)Return on assets | +1.5% | +5.6% | +1.2% | +4.2% |
| ROICReturn on invested capital | +3.0% | +21.9% | +4.8% | +1.9% |
| ROCEReturn on capital employed | +3.8% | +16.8% | +4.9% | +2.5% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.80x | 0.00x | 0.55x | 1.32x |
| Net DebtTotal debt minus cash | $656M | -$61M | $496M | $3.9B |
| Cash & Equiv.Liquid assets | $39M | $62M | $1.2B | $4M |
| Total DebtShort + long-term debt | $695M | $491,000 | $1.7B | $3.9B |
| Interest CoverageEBIT ÷ Interest expense | 3.54x | — | 12.76x | 5.98x |
Total Returns (Dividends Reinvested)
KNTK leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in KNTK five years ago would be worth $19,312 today (with dividends reinvested), compared to $4,462 for EYE. Over the past 12 months, EYE leads with a +46.3% total return vs AMSF's -29.2%. The 3-year compound annual growth rate (CAGR) favors KNTK at 24.7% vs NVST's -11.3% — a key indicator of consistent wealth creation.
| Metric | ||||
|---|---|---|---|---|
| YTD ReturnYear-to-date | -12.0% | -18.3% | +12.0% | +37.4% |
| 1-Year ReturnPast 12 months | +46.3% | -29.2% | +44.2% | +28.0% |
| 3-Year ReturnCumulative with dividends | +2.2% | -24.8% | -30.3% | +93.9% |
| 5-Year ReturnCumulative with dividends | -55.4% | -18.9% | -46.6% | +93.1% |
| 10-Year ReturnCumulative with dividends | -18.0% | +31.8% | -13.1% | -33.5% |
| CAGR (3Y)Annualised 3-year return | +0.7% | -9.1% | -11.3% | +24.7% |
Risk & Volatility
Evenly matched — AMSF and KNTK each lead in 1 of 2 comparable metrics.
Risk & Volatility
AMSF is the less volatile stock with a 0.23 beta — it tends to amplify market swings less than NVST's 1.65 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KNTK currently trades 94.8% from its 52-week high vs AMSF's 62.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||||
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.62x | 0.23x | 1.65x | 0.60x |
| 52-Week HighHighest price in past year | $30.02 | $48.54 | $30.42 | $51.11 |
| 52-Week LowLowest price in past year | $14.38 | $29.42 | $16.33 | $31.33 |
| % of 52W HighCurrent price vs 52-week peak | +76.0% | +62.4% | +79.8% | +94.8% |
| RSI (14)Momentum oscillator 0–100 | 40.8 | 34.2 | 55.1 | 51.3 |
| Avg Volume (50D)Average daily shares traded | 1.4M | 212K | 2.4M | 1.2M |
Analyst Outlook
KNTK leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: EYE as "Buy", AMSF as "Buy", NVST as "Hold", KNTK as "Buy". Consensus price targets imply 54.2% upside for EYE (target: $35) vs -1.8% for KNTK (target: $48). For income investors, KNTK offers the higher dividend yield at 16.47% vs AMSF's 8.41%.
| Metric | ||||
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $35.20 | $44.50 | $27.00 | $47.57 |
| # AnalystsCovering analysts | 14 | 6 | 19 | 15 |
| Dividend YieldAnnual dividend ÷ price | — | +8.4% | — | +16.5% |
| Dividend StreakConsecutive years of raises | 2 | 0 | — | 3 |
| Dividend / ShareAnnual DPS | — | $2.55 | — | $7.98 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +2.1% | +4.1% | +5.3% |
AMSF leads in 2 of 6 categories (Valuation Metrics, Profitability & Efficiency). KNTK leads in 2 (Total Returns, Analyst Outlook). 2 tied.
EYE vs AMSF vs NVST vs KNTK: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is EYE or AMSF or NVST or KNTK a better buy right now?
For growth investors, Kinetik Holdings Inc.
(KNTK) is the stronger pick with 19. 0% revenue growth year-over-year, versus 2. 6% for AMERISAFE, Inc. (AMSF). AMERISAFE, Inc. (AMSF) offers the better valuation at 12. 3x trailing P/E (14. 4x forward), making it the more compelling value choice. Analysts rate National Vision Holdings, Inc. (EYE) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — EYE or AMSF or NVST or KNTK?
On trailing P/E, AMERISAFE, Inc.
(AMSF) is the cheapest at 12. 3x versus Envista Holdings Corp at 86. 7x. On forward P/E, AMERISAFE, Inc. is actually cheaper at 14. 4x.
03Which is the better long-term investment — EYE or AMSF or NVST or KNTK?
Over the past 5 years, Kinetik Holdings Inc.
(KNTK) delivered a total return of +93. 1%, compared to -55. 4% for National Vision Holdings, Inc. (EYE). Over 10 years, the gap is even starker: AMSF returned +31. 8% versus KNTK's -33. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — EYE or AMSF or NVST or KNTK?
By beta (market sensitivity over 5 years), AMERISAFE, Inc.
(AMSF) is the lower-risk stock at 0. 23β versus Envista Holdings Corp's 1. 65β — meaning NVST is approximately 612% more volatile than AMSF relative to the S&P 500. On balance sheet safety, AMERISAFE, Inc. (AMSF) carries a lower debt/equity ratio of 0% versus 132% for Kinetik Holdings Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — EYE or AMSF or NVST or KNTK?
By revenue growth (latest reported year), Kinetik Holdings Inc.
(KNTK) is pulling ahead at 19. 0% versus 2. 6% for AMERISAFE, Inc. (AMSF). On earnings-per-share growth, the picture is similar: National Vision Holdings, Inc. grew EPS 202. 8% year-over-year, compared to -14. 5% for AMERISAFE, Inc.. Over a 3-year CAGR, KNTK leads at 13. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — EYE or AMSF or NVST or KNTK?
AMERISAFE, Inc.
(AMSF) is the more profitable company, earning 14. 9% net margin versus 1. 5% for National Vision Holdings, Inc. — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMSF leads at 18. 6% versus 3. 1% for EYE. At the gross margin level — before operating expenses — NVST leads at 55. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is EYE or AMSF or NVST or KNTK more undervalued right now?
On forward earnings alone, AMERISAFE, Inc.
(AMSF) trades at 14. 4x forward P/E versus 42. 4x for Kinetik Holdings Inc. — 28. 0x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for EYE: 54. 2% to $35. 20.
08Which pays a better dividend — EYE or AMSF or NVST or KNTK?
In this comparison, KNTK (16.
5% yield), AMSF (8. 4% yield) pay a dividend. EYE, NVST do not pay a meaningful dividend and should not be held primarily for income.
09Is EYE or AMSF or NVST or KNTK better for a retirement portfolio?
For long-horizon retirement investors, AMERISAFE, Inc.
(AMSF) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 23), 8. 4% yield). Envista Holdings Corp (NVST) carries a higher beta of 1. 65 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (AMSF: +31. 8%, NVST: -13. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between EYE and AMSF and NVST and KNTK?
These companies operate in different sectors (EYE (Consumer Cyclical) and AMSF (Financial Services) and NVST (Healthcare) and KNTK (Energy)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: EYE is a small-cap quality compounder stock; AMSF is a small-cap deep-value stock; NVST is a small-cap quality compounder stock; KNTK is a small-cap high-growth stock. AMSF, KNTK pay a dividend while EYE, NVST do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.